Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2002 | 1 |
2003 | 3 |
2009 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Increase in presenilin 1 (PS1) levels in senescence-accelerated mice (SAMP8) may indirectly impair memory by affecting amyloid precursor protein (APP) processing.
J Exp Biol. 2009 Feb;212(Pt 4):494-8. doi: 10.1242/jeb.022780.
J Exp Biol. 2009.
PMID: 19181896
Metabolism of rofecoxib in vitro using human liver subcellular fractions.
Slaughter D, Takenaga N, Lu P, Assang C, Walsh DJ, Arison BH, Cui D, Halpin RA, Geer LA, Vyas KP, Baillie TA.
Slaughter D, et al. Among authors: vyas kp.
Drug Metab Dispos. 2003 Nov;31(11):1398-408. doi: 10.1124/dmd.31.11.1398.
Drug Metab Dispos. 2003.
PMID: 14570773
Item in Clipboard
Acyl glucuronidation and glucosidation of a new and selective endothelin ET(A) receptor antagonist in human liver microsomes.
Tang C, Hochman JH, Ma B, Subramanian R, Vyas KP.
Tang C, et al. Among authors: vyas kp.
Drug Metab Dispos. 2003 Jan;31(1):37-45. doi: 10.1124/dmd.31.1.37.
Drug Metab Dispos. 2003.
PMID: 12485951
Item in Clipboard
The disposition and metabolism of rofecoxib, a potent and selective cyclooxygenase-2 inhibitor, in human subjects.
Halpin RA, Porras AG, Geer LA, Davis MR, Cui D, Doss GA, Woolf E, Musson D, Matthews C, Mazenko R, Schwartz JI, Lasseter KC, Vyas KP, Baillie TA.
Halpin RA, et al. Among authors: vyas kp.
Drug Metab Dispos. 2002 Jun;30(6):684-93. doi: 10.1124/dmd.30.6.684.
Drug Metab Dispos. 2002.
PMID: 12019196
Item in Clipboard
Novel 5-cyclopropyl-1,4-benzodiazepin-2-ones as potent and selective I(Ks)-blocking class III antiarrhythmic agents.
Butcher JW, Liverton NJ, Claremon DA, Freidinger RM, Jurkiewicz NK, Lynch JJ, Salata JJ, Wang J, Dieckhaus CM, Slaughter DE, Vyas K.
Butcher JW, et al. Among authors: vyas k.
Bioorg Med Chem Lett. 2003 Mar 24;13(6):1165-8. doi: 10.1016/s0960-894x(03)00049-0.
Bioorg Med Chem Lett. 2003.
PMID: 12643935
Item in Clipboard
Cite
Cite